Regulation of CD95 (APO-1) Expression and the Induction of Apoptosis in Human T Cells: Changes in Old Age

International Archives of Allergy and Immunology

Volumn 110, Issue 3, 1996, Pages 238-243

  Lechner, H ^a   Amort, M ^a   Steger, M M ^a   Maczek, C ^a   Grubeck Loebenstein, Beatrix ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Aging; Apoptosis; CD95; T lymphocytes

Indexed keywords

FAS ANTIGEN; OKT 3;

AGING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; DETERIORATION; ETIOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0029977502     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237293     Document Type: Article

References (31)

1. Freitas AA, Rocha BB: Lymphocyte lifespans: Homeostasis, selection and competition, Immunol Today 1993;14:25-29.
2. Akbar AN, Salmon M, Savill J, Janossy G: A possible role for ltd-2 in regulating T cell memory: A ‘balancing act' between cell death and survival, Immunol Today 1993;14:526-532.
3. Sprcnt J: T and B memory cells, Cell 1994;76: 315-322.
4. Itoh N, Yonehara S, Ishii A, Yonehara M, Mi-zushima SI, Sameshima M, Hase A, Scto Y, Na-gata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell 1991;66:233-243.
5. Oclim A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhcin J, Trauth BC, Ponstingl H, Krammer PH: Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor supcrfamily, J Biol Client 1992:267: 10709-10715.
6. Suda T, Takahashi T, Golstcin P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family, Cell 1993;78:1169-1178.
7. Suda T, Nagata S: Purification and characterization of the Fas-ligand that induces apoptosis, J Exp Med 1994:179:873-879.
8. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, Debatin KM, Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science 1989; 245:301-305.
9. Klas C, Debatin KM, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells, Int Immunol 1993;5: 625-630.
10. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes, J Exp Med 1995; 181:71 — 77.
11. Vignaux F, Vivier E, Malissen B, Depractcre V, Nagata S, Golstein P: TCR/CD3 coupling to Fas-bascd cytotoxicity, J Exp Med 1995; 181: 781-786.
12. Zhou T, Edwards CK III, Mountz JD: Prevention of age-related T cell apoptosis defect in CD2-/ds-transgenic mice, J Exp Med 1995:182: 129-137.
13. Thoman ML, Weigle WO: The cellular and sub-cellular bases of immunosenescence, Adv Immunol 1989;46:221-261.
14. Song L, Kim YH, Chopra RK, Proust JJ, Nagel JE, Nordin AA, Adler WH: Age-related effects in T cell activation and proliferation, Exp Gerontol 1993;28:313-321.
15. Effros RB: Immunosenescence related diseases in the elderly, Immunol Allergy Clin 1993; 13: 695-712.
16. Miller RA: Aging and immune function: Cellular and biochemical analyses, Exp Gerontol 1994;29:21-35.
17. Schwab R, Pfeffer LM, Szabo P, Gamble D, Schnurr CM, Weksler ME: Defective expression of high affinity IL-2 receptors on activated T cells from aged humans, Int Immunol I990;2: 239-246.
18. Ligthart GJ, Corberand JX, Fournier C, Gala-naud P, Hijmans W, Kcnnes B, Müller-Hermc-link HK, Steinmann GG: Admission criteria for immunogerontological studies in man: The Se-nieur protocol, Mcch Ageing Dev 1984;28:47-55.
19. Rcibncgger G, Huber LA, Jürgens G, Schönit-zcr D, Werner ER, Wächter H, Wick G, Traill KN: Approach to define ‘normal aging’ in man: immune function, serum lipids, lipoproteins and neopterin levels, Mech Ageing Dev 1988; 46:67-82.
20. Nicoletti I, Migliorati G, Pagliacci MC, Grigna-ni F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow' cytometry, J Immunol Methods 1991;139:271-279.
21. Grubeck-Loebcnstcin B, Lechner H, Trieb K: Long-term in vitro growth of human T cell clones: Can postmitotic ‘senescent’ cell populations be defined? Int Arch Allergy Immunol 1994;104:232-239.
22. Fiilöp T Jr., Barabas G, Varga Z, Jozsef C, Csabi-na S, Szucs S, Seres I, Szikszay E, Jeney Z, Pc-nyige A: Age-dcpcndcnt changes in transmembrane signalling: Identification of G proteins in human lymphocytes and polymorphonuclear leukocytes, Cell Signal 1993:5:593-603.
23. Huber LA, Xu QB, Jürgens G, Böck G, Bühler E, Fred Gey K, Schönitzer D, Traill KN, Wick G: Correlation of lymphocyte lipid composition membrane microviscosity and mitogen response in the aged, Eur J Immunol 1991 ;21: 2761-2765.
24. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN: The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis, Eur J Immunol 1994;24:892-899.
25. Sprent J, Tough DF: Lymphocyte life-span and memory, Science 1994;265:1395-1400.
26. Burns EA, Lum LG, L’Hommcdicu G, Goodwin JS: Specific humoral immunity in the elderly: In vivo and in vitro response to vaccination, J Gerontol 1993;48:B231-B236.
27. Walford RL, Jawaid SQ, Nacim F: Evidence for in vitro senescence of T lymphocytes cultured from normal human peripheral blood, Age 1981;4:67-71.
28. McCarron M, Osborne Y, Story CJ, Dempsey JL, Turner DR, Morlcy AA: Effect of age on lymphocyte proliferation, Mech Ageing Dev 1987;41:211-218.
29. Stegcr MM, Grubeck-Loebenstein B: Antigen presentation by dendritic cells (DC) can prevent activation driven apoptosis in senescent T cell populations and rescue them from elimination, Immunobiol 1995; 194:64 (D.23).
30. Stingl G, Bergstresser PR: Dendritic cells: A major story unfolds, Immunol Today 1995; 16: 330-333.
31. Baier G, Baier-Bitterlich G, Looney DJ, Altman A: Immunogenic targeting of recombinant peptide vaccines to human antigen presenting cells by chimeric anti-HLA-DR and anti-sIgD antibody Fab fragments in vitro, J Virol 1995; 69:2357-2365.